Photo:

Prostate cancer

Prostate cancer (PCa) is not only one of the most common, but also one of the deadliest types of cancer in men. Diagnostics are correspondingly sophisticated, from imaging via ultrasound or MRI to various biopsy techniques – often even in combination. Keep reading for current developments in early detection, staging, therapy and research.

Photo

News • Combined approach

Prostate cancer: PSMA PET/CT-targeted biopsy improves detection

A combined approach of two biopsy techniques involving PSMA PET/CT may help identify clinically significant prostate cancer that would otherwise be difficult to detect, according to new research.

Photo

Sponsored • New Whitepaper

AI-Enabled Care Pathway: Shifting the Paradigm in Prostate Cancer Diagnosis

Prostate cancer is the second most common cancer in men worldwide. As clinical guidelines increasingly recommend MRI before biopsy, prostate MRI has become a critical decision point in the diagnostic…

Photo

News • Mutational process analysis

Scientists explore DNA damage in prostate cancer for better predictions

New research offers an explanation for why many men live with prostate cancer for decades while for others it turns lethal: The work identifies which processes cause DNA damage in most of the cancers.

Photo

News • Gesture sequence recognition and clinical outcome prediction

Prostate cancer: AI analyzes surgical technique to improve care

A newly developed AI system analyzes surgeons’ techniques during prostate cancer surgery, helping identify the surgical movements associated with the best patient outcomes.

Photo

News • After an initial negative scan

Treatment change for prostate cancer: study reveals benefit of second PSMA PET

A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of prostate cancer patients whose first scan was negative, according to new research.

Photo

News • Exploring the landscape of tumour methylation

Parsing the pathology of prostate cancer

Why do some prostate cancers grow slowly and remain localized while others become aggressive and metastasize? In a new paper, researchers identify the answer: tumor methylation.

202 show more articles
Subscribe to Newsletter